| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 10/31/2002 | WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/31/2002 | WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof |
| 10/31/2002 | WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 10/30/2002 | EP1253140A1 Process for cyclizing optically active 4-amino-2-halogenobutyric acids |
| 10/30/2002 | EP1252166A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
| 10/30/2002 | CN1377268A Cell adhesion inhibitors |
| 10/30/2002 | CN1376677A [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application |
| 10/29/2002 | CA2342471C Heterocyclecarbonylmethyl amine intermediates |
| 10/24/2002 | WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 10/24/2002 | US20020156314 Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
| 10/22/2002 | CA2227264C Amine acid salt compounds and process for the production thereof |
| 10/17/2002 | US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 10/16/2002 | EP0906278B1 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones |
| 10/16/2002 | EP0827961B1 Process for the preparation of beta-lactam compounds |
| 10/10/2002 | WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 10/10/2002 | US20020147335 Anticancer, antitumor agents |
| 10/10/2002 | US20020147184 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 10/09/2002 | EP1246795A2 Antibacterial agents |
| 10/08/2002 | US6462208 C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them |
| 10/08/2002 | US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents |
| 10/08/2002 | US6462021 Melagatran or derivative; nonvalvular atrial fibrillation; thrombotic or ischemic stroke, transient ischemic attack or systemic embolism |
| 10/03/2002 | WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | WO2002076177A2 Design and synthesis of optimized ligands for ppar |
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/02/2002 | EP0690853B1 Taxanes prepared by beta-lactams and ammonium alkoxides |
| 10/01/2002 | US6458977 Taxane derivatives as anticarcinogenic or antitumor agents |
| 10/01/2002 | CA2050993C Intermediates to 1-carbacephalosporins and process for preparation thereof |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137927 Intermediates in the preparation of sidechain-bearing taxanes such as taxol and taxol derivatives. |
| 09/26/2002 | US20020137690 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 09/26/2002 | US20020137689 Hypolipidemic agents |
| 09/25/2002 | EP1243577A1 Novel phenylalanine derivatives |
| 09/25/2002 | EP1242370A1 Synthesis of chiral 2-azetidinemethanol compounds |
| 09/25/2002 | EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections |
| 09/25/2002 | EP0840724B1 Process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
| 09/24/2002 | US6455671 Thrombin inhibitors, the preparation and use thereof |
| 09/18/2002 | EP1241174A1 Chiral ligands for asymmetric synthesis |
| 09/17/2002 | US6451829 Coumarinic compounds having IgE affecting properties |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451819 Pyrrolidine-3-yl-sulfanyl, or sufonyl or sufinyl derivatives used in the treatment of neurodegenerative diseases |
| 09/17/2002 | US6451785 Beta lactams as antiproliferative agents |
| 09/12/2002 | WO2002070519A1 Monobactams as cathepsin k inhibitors |
| 09/12/2002 | WO2002070512A1 Method for producing 2-azetidinone derivative |
| 09/12/2002 | WO2002070498A1 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 09/12/2002 | WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof |
| 09/12/2002 | WO2002044113A3 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/12/2002 | US20020128452 Coupling Process |
| 09/12/2002 | US20020128253 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | US20020128252 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | CA2438829A1 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/11/2002 | CN1090479C Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor |
| 09/10/2002 | US6448414 Hydrolytic kinetic resolution of cyclic substrates |
| 09/10/2002 | CA2087967C Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 09/06/2002 | WO2002020476A3 Crystalline forms of carbapenem intermediates |
| 09/05/2002 | US20020122857 Adding an organic solvent to an aqueous extract of soybeans and purifying precipitate |
| 09/04/2002 | EP0883620B1 Process for the preparation of 2-halomethyl-penems and their use for the preparation of antibacterial penems |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 08/29/2002 | US20020120154 Method for preparing lactam |
| 08/29/2002 | US20020119992 Anticoagulants |
| 08/27/2002 | US6441189 Process for the preparation of matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002032377A3 Estrogen receptor modulators |
| 08/22/2002 | US20020115806 Olefin polymerization catalyst system is a reaction product of a metallocenes and a cocatalyst containing fluoroaryl substituted secondary amine or phsophine compound and an anion containing group 13 element which is noncoordinatig |
| 08/15/2002 | US20020111265 Group-15 cationic compounds for olefin polymerization catalysts |
| 08/13/2002 | US6433186 Treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants. |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/07/2002 | EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain |
| 08/01/2002 | WO2002058734A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 08/01/2002 | WO2002058731A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 08/01/2002 | WO2002058696A2 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/01/2002 | WO2002058685A2 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 08/01/2002 | CA2434504A1 Combinations of sterol absorption inhibitor(s) with blood modifiers for treating vascular conditions |
| 08/01/2002 | CA2434488A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2434436A1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 08/01/2002 | CA2434430A1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | US20020099205 Cyclization of (2-Oxo-4-(2-oxo-2-(tetrahydrofuran-2-yl)-ethylsulfanyl)-3-phenylacetylamino -azetidin-1-yl)-(trimethyl- alpha -phosphanylidene)-acetic acid 4-nitro-benzyl ester; reacting with acid |
| 07/24/2002 | EP1225176A2 Process for preparing exo-methylenepenam compounds |
| 07/17/2002 | EP1222305A2 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams |
| 07/17/2002 | EP1049670B1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/17/2002 | CN1359389A Substantially crystalline form of melagatran |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/11/2002 | WO2002026750A3 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 07/11/2002 | WO2002026705A3 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 07/11/2002 | US20020091274 Taxane derivatives having an amino substituted C13 side chain useful as antileukemia and antitumor agents |
| 07/10/2002 | CN1358174A New Compounds |
| 07/09/2002 | US6417373 Aza azetidinium sulfate compounds chemical intermediates for propellants and explosives |
| 07/09/2002 | US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | US20020087013 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |